LOGIN  |  REGISTER
Cue Biopharma

Recent Insider Transactions - Precigen (NASDAQ: PGEN)

Follow NASDAQ:PGEN Visit website
Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ PGEN Precigen
Thomasian Harry Jr. / officer: Chief Financial Officer
05/23/2025
Buy
$1.37
350,000
$480K
350,000
NASDAQ PGEN Precigen
Lehr Donald P. / officer: Chief Legal Officer
05/23/2025
Buy
$1.37
250,000
$343K
250,000
NASDAQ PGEN Precigen
Shah Rutul R / officer: Chief Operating Officer
05/23/2025
Buy
$1.37
360,000
$493K
360,000
NASDAQ PGEN Precigen
Tennant Phil / officer: Chief Commercial Officer
05/23/2025
Buy
$1.37
250,000
$343K
250,000
NASDAQ PGEN Precigen
Sabzevari Helen / director, officer: President and CEO
05/23/2025
Buy
$1.37
1,000,000
$1.370M
1,000,000
NASDAQ PGEN Precigen
Shah Rutul R / officer: Chief Operating Officer
05/16/2025
Sell
$1.45
58,096
$84K
403,959
NASDAQ PGEN Precigen
Tennant Phil / officer: Chief Commercial Officer
05/16/2025
Sell
$1.45
22,969
$33K
59,031
NASDAQ PGEN Precigen
Lehr Donald P. / officer: Chief Legal Officer
05/16/2025
Sell
$1.45
55,101
$80K
681,649
NASDAQ PGEN Precigen
Thomasian Harry Jr. / officer: Chief Financial Officer
05/16/2025
Sell
$1.45
51,441
$75K
457,410
NASDAQ PGEN Precigen
Sabzevari Helen / director, officer: President and CEO
05/16/2025
Sell
$1.45
521,224
$756K
3.32M

  Research Tools
  News & Announcements
  Popular Topics
  Miscellaneous